Gene Therapy - 3/8

by in

Entry	Author	Date	Location
Genzyme Gene Therapy Fails To Help People with Leg Disease Walk Longer	Luke Timmerman	03/31/09	Boston
Sticking to its Guns with Gene Therapy, Genzyme To Present Key Findings Within Days	Luke Timmerman	03/25/09	Boston
Biogen Idec Aims to Regenerate Damaged Nerves, Crack Multi-Billion Dollar Market	Luke Timmerman	03/11/09	Boston
Targeted Genetics Hands Off Manufacturing	Luke Timmerman	03/02/09	Seattle
Biogen Idec Takes Aim at New Parkinson’s Paradigm	Luke Timmerman	01/05/09	Boston
Ceregene Drug Fails in Parkinson’s Trial	Luke Timmerman	12/01/08	San Diego
Stewart Parker Resigns from Board of Targeted Genetics, Susan Robinson Takes Her Spot	Luke Timmerman	11/17/08	Seattle
Stewart Parker Resigns from Targeted Genetics After Gene Therapy Setbacks	Luke Timmerman	11/10/08	Seattle
Targeted Genetics Cash Will Stretch into First Quarter	Luke Timmerman	11/05/08	Seattle
Ceregene Awaits Parkinson’s Trial Results, In a Key Test for Gene Therapy	Luke Timmerman	10/31/08	San Diego
Genzyme Forges Chinese Connection to Speed Gene Therapy to World Market	Malorye Allison	10/29/07	Boston
Page 3 of 3	« previous page

Xconomy National